Skip to main content

FDA rescinds emergency authorization for COVID-19 antibody treatment b...

The Food and Drug Administration (FDA) rescinded its emergency use authorization for the monoclonal antibody bamlanivimab to be used on its own as treatment against COVID-19 due to variants' resistance to the therapy.
FDA rescinds emergency authorization for COVID-19 antibody treatment b... image

FDA rescinds emergency authorization for COVID-19 antibody treatment bamlanivimab | TheHill - The Hill

The Food and Drug Administration (FDA) rescinded its emergency use authorization for the monoclonal antibody bamlanivimab to be used on its own as treatment against COVID-19 due to variants' resistance to the therapy.
Read More

In Similar Category

From The Hill